amobarbital has been researched along with External Ophthalmoplegia in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ireland, MA | 1 |
Berghouse, LM | 1 |
Meador, KJ | 1 |
Loring, DW | 1 |
Lee, GP | 1 |
Brooks, BS | 1 |
Nichols, FT | 1 |
Thompson, EE | 1 |
Thompson, WO | 1 |
Heilman, KM | 1 |
2 other studies available for amobarbital and External Ophthalmoplegia
Article | Year |
---|---|
Supranuclear palsy in barbiturate intoxication.
Topics: Adult; Amobarbital; Eye Movements; Female; Humans; Ophthalmoplegia | 1979 |
Hemisphere asymmetry for eye gaze mechanisms.
Topics: Adolescent; Adult; Amobarbital; Biomechanical Phenomena; Carotid Arteries; Dominance, Cerebral; Eye; | 1989 |